Cargando…
Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors
Cutaneous basal cell carcinoma (BCC) is the most common human cancer and its incidence is rising worldwide. Ultraviolet radiation exposure, including tanning bed use, as well as host factors play a role in its development. The majority of cases are treated and cured with local therapies including su...
Autores principales: | Fecher, Leslie A, Sharfman, William H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642804/ https://www.ncbi.nlm.nih.gov/pubmed/26604681 http://dx.doi.org/10.2147/BTT.S54179 |
Ejemplares similares
-
Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Aditya, Suruchi, et al.
Publicado: (2013) -
Impact of the Smoothened Inhibitor, IPI-926, on Smoothened Ciliary Localization and Hedgehog Pathway Activity
por: Peluso, Marisa O., et al.
Publicado: (2014) -
Hedgehog pathway as a drug target: Smoothened inhibitors in development
por: Lin, Tara L, et al.
Publicado: (2012) -
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
por: Doan, Hung Q, et al.
Publicado: (2016) -
The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis
por: Chai, Jian Yi, et al.
Publicado: (2021)